Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
|
Healthcare professional (hcp) reported that a patient was injected in the jawline with juvéderm® volux¿ xc.Right after treatment, the patient quickly developed a large, mottled, dark, unilateral spot in the treatment area.There was no blanching seen during this time.The hcp¿s medical director who is a plastic surgeon determined it was a venous vascular occlusion and the patient was treated the same day with hylenex, heat, aspirin, nitro paste, and a massage.The hylenex was delivered broadly in the area for two sessions, with 10 cc being injected 1st and 3 cc being injected later.Hcp stated that the patient¿s capillary refill had returned to normal and plans to watch them closely as they recover over the next several days.
|